Clinical Trial Update: Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for lenvatinib plus pembrolizumab in stage IVB unresectable or stage IVC metastatic anaplastic thyroid cancer, with ACTIVE_NOT_R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma
• Poorly Differentiated Thyroid Carcinoma
• Thyroid Carcinoma
• Thyroid Squamous Cell Carcinoma
• Unresectable Thyroid Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING